Literature DB >> 12946535

Stereospecific high-performance liquid chromatographic analysis of flurbiprofen: application to pharmacokinetic studies.

Xiao Wei Teng1, Stephen W J Wang, Neal M Davies.   

Abstract

A method of analysis of flurbiprofen (+/- 2-(2-fluoro-4-biphenyl)-propionic acid) in biological fluids is necessary to study the kinetics of in vitro and in vivo metabolism and tissue distribution. A simple high-performance liquid chromatographic method was developed for simultaneous determination of flurbiprofen enantiomers in rat serum. Serum (0.1 ml) was extracted with 2,2,4-trimethylpentane-isopropanol (95:5, v/v) after addition of the internal standard (IS), S-naproxen and acidification with H(2)SO(4). Separation was achieved on a Chiralpak AD-RH column with UV detection at 247 nm. The calibration curve was linear ranging from 0.05 to 50 microg/ml for each enantiomer. The mean extraction efficiency was >95%. Precision of the assay was <11% (CV), and was within 12.6% at the limit of quantitation (LOQ) (0.05 microg/ml). Bias of the assay was lower than 13.1%, and was within 12.8% at the LOQ. The assay was applied successfully to the in vivo kinetic study of flurbiprofen in rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946535     DOI: 10.1016/s0731-7085(03)00340-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Direct and indirect high-performance liquid chromatography enantioseparation of trans-4-hydroxy-2-nonenoic acid.

Authors:  Jiri Brichac; Ales Honzatko; Matthew J Picklo
Journal:  J Chromatogr A       Date:  2007-03-21       Impact factor: 4.759

2.  Fabrication, In Vitro and In Vivo Evaluation of Non-Ordered Mesoporous Silica-Based Ternary Solid Dispersions for Enhanced Solubility of Flurbiprofen.

Authors:  Muhammad Usman Munir; Mahnoor Ikraam; Muhammad Nadeem; Syed Haroon Khalid; Sajid Asghar; Ikrima Khalid; Muhammad Irfan; Nayyer Islam; Nyla Ajaz; Ikram Ullah Khan
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.